Family Medicine · Anniston, AL
NPI
1134106800
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
400 E 8th St
Anniston, AL, 36207
Phone (256) 237-8527
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
2,225 services
Medicare patients, 2024
325
Average age 76
Drug cost, 2024
$1.1M
12,809 prescriptions
Company payments, 2025
$1,768
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Chalk was code 99214 (office e&m - established), 884 times for 268 patients. In total David A Chalk billed 2,225 services in 50 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 884 | 268 | $77.35 | $68K |
| 11045 Debridement | Facility | 213 | 11 | $17.39 | $3,704 |
| 11042 Debridement | Facility | 212 | 29 | $41.27 | $8,749 |
| 96372 Injection Administration | Office | 107 | 57 | $8.39 | $898 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 107 | 38 | $4.47 | $479 |
| G0008 Administration of influenza virus vaccine | Office | 85 | 85 | $29.46 | $2,504 |
| 90662 Vaccine Product | Office | 82 | 82 | $81.58 | $6,689 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 69 | 69 | $122.95 | $8,484 |
| 99213 Office E&M - Established | Office | 62 | 33 | $55.91 | $3,466 |
| 81003 Clinical Chemistry | Office | 45 | 33 | $2.20 | $99 |
| 87804 Immunoassay | Office | 41 | 19 | $16.10 | $660 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 38 | 16 | $0.37 | $14.05 |
| 87426 Immunoassay | Office | 28 | 24 | $34.54 | $967 |
| G0009 Administration of pneumococcal vaccine | Office | 25 | 25 | $29.46 | $737 |
| 90677 Vaccine Product | Office | 21 | 21 | $292.08 | $6,134 |
By year: 2022 $134K for 2,644 services; 2023 $115K for 2,286 services; 2024 $121K for 2,225 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 45 | 33 | $2.20 | $99 |
| 87804 Immunoassay | 41 | 19 | $16.10 | $660 |
| 87426 Immunoassay | 28 | 24 | $34.54 | $967 |
| 36415 Venipuncture Blood Collection | 14 | 13 | $4.90 | $68.6 |
Medicare prescription drug claims, 2024
In 2024, the drug David A Chalk prescribed most often to Medicare patients was Atorvastatin Calcium, with 553 prescriptions and refills. In total David A Chalk wrote 12,809 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 553 | 1,573 | 170 | $7,611 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 460 | 460 | 84 | $11K |
| Amlodipine Besylate Generic | 365 | 1,027 | 112 | $2,655 |
| Pantoprazole Sodium Generic | 348 | 964 | 117 | $4,406 |
| Gabapentin Generic | 342 | 575 | 98 | $4,334 |
| Levothyroxine Sodium Generic | 303 | 762 | 80 | $3,094 |
| Losartan Potassium Generic | 270 | 724 | 82 | $3,378 |
| Tizanidine Hcl Generic | 260 | 413 | 73 | $3,153 |
| Hydrochlorothiazide Generic | 260 | 731 | 72 | $1,431 |
| Clonazepam Generic | 239 | 268 | 37 | $1,471 |
| Alprazolam Generic | 231 | 241 | 37 | $798 |
| Tramadol Hcl Generic | 226 | 226 | 62 | $1,354 |
| Carvedilol Generic | 220 | 571 | 63 | $1,981 |
| Omeprazole Generic | 216 | 614 | 67 | $3,613 |
| Trazodone Hcl Generic | 200 | 465 | 57 | $2,362 |
Brand drugs: 1,377 claims; generic drugs: 11,397 claims; opioid claims: 910.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Chalk $1,768 ($1,768 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $300.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 18 | $300 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $190 |
| Merck Sharp & Dohme LLC MRK | 8 | $187 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $182 |
| Abbvie Inc. ABBV | 11 | $147 |
| Melinta Therapeutics, LLC | 5 | $115 |
| Paratek Pharmaceuticals, Inc. | 5 | $103 |
| GlaxoSmithKline, LLC. GSK | 5 | $83.64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $78.39 |
| Amgen Inc. AMGN | 5 | $71.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.